NCT04887194 2024-05-08PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of SubstratesMirati Therapeutics Inc.Phase 1 Completed40 enrolled
NCT02908750 2022-11-14Study to Assess the Effect of Osimertinib (TAGRISSOâ„¢ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLCAstraZenecaPhase 1 Completed24 enrolled